Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.15 EUR
26.13 M EUR
174.85 M EUR
13.06 M
About PHARMA MAR, S.A.
Sector
Industry
CEO
José Maria Fernández de Sousa-Faro
Website
Headquarters
Colmenar Viejo
Founded
1986
ISIN
ES0169501022
FIGI
BBG00NL2WH99
Pharma Mar SA is a biopharmaceutical holding company, which engages in research, development, production, and commercialization of bio-active principles of marine origin for application in oncology. It operates through the following segments: Oncology, Diagnostics, and RNAi. The Oncology segment focuses to the group undertakings whose object is to research, develop, and market anti-tumour drugs. The Diagnostics segment focuses in the development and marketing of diagnostic kits. The RNAi segment develops drugs with therapeutic activity based on reducing or silencing gene expression. The company was founded by José Maria Fernández de Sousa-Faro on April 30, 1986 and is headquartered in Colmenar Viejo, Spain.
Related stocks
Pharmamar PHMGood morning, today I present the analysis of PHM, a Spanish company pharmamar in the race for the vaccine against Covid19.
It is being a great trading year for this company.
The bullish structure marked by the yellow arrow has been broken, but the new structure, the bearish one, has not yet consoli
Pharmamar may reach 7,06€ +50%It seems that Pharmamar may reach 7,06€ (+50% from current price) after activating an iSHS and improving its rating.
See all ideas
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on AQUISEU exchange Pharma Mar SA stocks are traded under the ticker PHME.
We've gathered analysts' opinions on Pharma Mar SA future price: according to them, PHME price has a max estimate of 118.00 EUR and a min estimate of 30.00 EUR. Watch PHME chart and read a more detailed Pharma Mar SA stock forecast: see what analysts think of Pharma Mar SA and suggest that you do with its stocks.
PHME reached its all-time high on Oct 16, 2020 with the price of 146.80 EUR, and its all-time low was 0.90 EUR and was reached on Oct 25, 2018. View more price dynamics on PHME chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
Yes, you can track Pharma Mar SA financials in yearly and quarterly reports right on TradingView.
Pharma Mar SA is going to release the next earnings report on Jul 24, 2025. Keep track of upcoming events with our Earnings Calendar.
PHME earnings for the last quarter are −0.11 EUR per share, whereas the estimation was 0.32 EUR resulting in a −134.92% surprise. The estimated earnings for the next quarter are 0.03 EUR per share. See more details about Pharma Mar SA earnings.
Pharma Mar SA revenue for the last quarter amounts to 38.90 M EUR, despite the estimated figure of 37.63 M EUR. In the next quarter, revenue is expected to reach 35.80 M EUR.
PHME net income for the last quarter is −3.95 M EUR, while the quarter before that showed 18.68 M EUR of net income which accounts for −121.14% change. Track more Pharma Mar SA financial stats to get the full picture.
Pharma Mar SA dividend yield was 1.00% in 2024, and payout ratio reached 53.71%. The year before the numbers were 1.58% and 1.02 K% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Pharma Mar SA EBITDA is 11.48 M EUR, and current EBITDA margin is 5.34%. See more stats in Pharma Mar SA financial statements.
Like other stocks, PHME shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Pharma Mar SA stock right from TradingView charts — choose your broker and connect to your account.